Skip Navigation

About
Team
News
Portfolio
Contact

Acquired by Merck in 2020

Back

14 November 2019

Themis

2023-11-16 // Adjuvant Capital OPIM Disclosure Statement

Site by Manoverboard ©2024 Adjuvant Capital

Have an investment idea or a question? Get in touch.

Contact us